32 results match your criteria ALA Dehydratase Deficiency Porphyria

  • Page 1 of 1

Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs).

Mol Genet Metab 2019 Mar 6. Epub 2019 Mar 6.

Section on Gastroenterology & Hepatology, Wake Forest University School of Medicine/NC Baptist Hospital, Winston-Salem, NC 27157, United States of America.

The acute hepatic porphyrias include four disorders: acute intermittent porphyria [AIP], hereditary coproporphyria [HCP], variegate porphyria [VP], and the rare porphyria due to severe deficiency of ALA dehydratase [ADP]. In the USA, AIP is the most severe and most often symptomatic. AIP, HCP, and VP are due to autosomal dominant genetic abnormalities, in which missense, nonsense, or other mutations of genes of normal hepatic heme biosynthesis, in concert with other environmental, nutritional, hormonal and genetic factors, may lead to a critical deficiency of heme, the end-product of the pathway, in a small but critical 'regulatory pool' within hepatocytes. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10967192193008
Publisher Site
http://dx.doi.org/10.1016/j.ymgme.2019.03.002DOI Listing
March 2019
2 Reads

Acute Hepatic Porphyrias: Review and Recent Progress.

Hepatol Commun 2019 Feb 20;3(2):193-206. Epub 2018 Dec 20.

Section of Gastroenterology and Hepatology, Department of Internal Medicine Wake Forest University School of Medicine Winston-Salem NC.

The acute hepatic porphyrias (AHPs) are a group of four inherited diseases of heme biosynthesis that present with episodic, acute neurovisceral symptoms. The four types are 5-aminolevulinic acid (ALA) dehydratase deficiency porphyria, acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria. Their diagnoses are often missed or delayed because the clinical symptoms mimic other more common disorders. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hep4.1297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357830PMC
February 2019
12 Reads

Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments.

Curr Opin Hematol 2017 May;24(3):198-207

aINSERM U1149 CNRS ERL 8252, Centre de Recherche sur l'inflammation, Université Paris Diderot, site Bichat, Sorbonne Paris Cité bLaboratory of excellence, GR-Ex, Paris cAP-HP, Centre Français des Porphyries, Hôpital Louis Mourier, Colombes dAP-HP, Hôpital Beaujon, Service de Biochimie Clinique, Clichy, France.

Purpose Of Review: Many studies over the past decade have together identified new genes including modifier genes and new regulation and pathophysiological mechanisms in inherited inborn diseases of the heme biosynthetic pathway. A new porphyria has been characterized: X-linked protoporphyria and the perspective to have innovative treatment at very short-term became a reality. We will summarize how recent data on both ALAS1 and ALAS2 have informed our understanding of disease pathogenesis with an emphasis on how this information may contribute to new therapeutic strategies. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00062752-201705000-0000
Publisher Site
http://dx.doi.org/10.1097/MOH.0000000000000330DOI Listing
May 2017
12 Reads

Acute Porphyrias.

J Emerg Med 2015 Sep 7;49(3):305-12. Epub 2015 Jul 7.

Department of Medicine, University of Connecticut, Farmington, Connecticut; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.

Background: Porphyrias are a group of eight metabolic disorders characterized by defects in heme biosynthesis. Porphyrias are classified into two major categories: 1) the acute or inducible porphyrias and 2) the chronic cutaneous porphyrias. The acute hepatic porphyrias are further classified into acute intermittent porphyria (AIP), hereditary coproporphyria, variegate porphyria, and porphyria due to severe deficiency of delta-aminolevulinic acid (ALA) dehydratase (ALADP). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2015.04.034DOI Listing
September 2015
25 Reads

Clinically important features of porphyrin and heme metabolism and the porphyrias.

Metabolites 2014 Nov 3;4(4):977-1006. Epub 2014 Nov 3.

Department of Medicine, Universities of CT, Farmington, CT 06030 and North Carolina, Chapel Hill, NC 27599, USA.

Heme, like chlorophyll, is a primordial molecule and is one of the fundamental pigments of life. Disorders of normal heme synthesis may cause human diseases, including certain anemias (X-linked sideroblastic anemias) and porphyrias. Porphyrias are classified as hepatic and erythropoietic porphyrias based on the organ system in which heme precursors (5-aminolevulinic acid (ALA), porphobilinogen and porphyrins) are chiefly overproduced. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/metabo4040977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279155PMC
November 2014
10 Reads

Direct assay of delta-aminolevulinic acid dehydratase in heme biosynthesis for the detection of porphyrias by tandem mass spectrometry.

Anal Chem 2010 Aug;82(15):6730-6

Department of Chemistry, University of Washington, Seattle, Washington 98195-1700, USA.

We report a new assay of human delta-aminolevulinic acid dehydratase (ALAD), an enzyme converting delta-aminolevulinic acid (ALA) into porphobilinogen. The assay is developed for use in the clinical diagnosis of delta-aminolevulinic acid dehydratase-deficient porphyria, a rare enzymatic deficiency of the heme biosynthetic pathway. The assay involves the incubation of erythrocyte lysate with the natural substrate, ALA, followed by quantitative in situ conversion of porphobilinogen to its butyramide, and liquid-liquid extraction into a mass spectrometer-friendly solvent. Read More

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/abs/10.1021/ac101111m
Publisher Site
http://dx.doi.org/10.1021/ac101111mDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913591PMC
August 2010
15 Reads

Porphyria syndrome associated with diabetic nephrosclerosis and erythropoietin.

Compr Ther 2006 ;32(3):163-71

Department of Medicine, Northwestern University Medical School, Chicago, IL, USA.

The porphyrias are inherited or acquired metabolic disorders caused by a partial deficiency in one of the enzymes of the heme biosynthetic pathway. Eight enzymes are utilized in the synthesis of heme. An enzyme defect in one of the last seven enzymes will result in one of the seven different forms of porphyria, some of which have similar signs and symptoms. Read More

View Article

Download full-text PDF

Source
May 2007
17 Reads

Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient.

Br J Haematol 2006 Jan;132(2):237-43

Okayama Prefectural University, Japan.

Summary A Caucasian male had symptoms of acute porphyria, with increases in urinary delta-aminolaevulinic acid (ALA), porphobilinogen (PBG) and coproporphyrin that were consistent with hereditary coproporphyria (HCP). However, a greater than expected increase in ALA, compared with PBG, and a substantial increase in erythrocyte zinc protoporphyrin, suggested additional ALA dehydratase (ALAD) deficiency. Nucleotide sequence analysis of coproporphyrinogen oxidase (CPO) cDNA of the patient, but not of the parents, revealed a novel nucleotide transition G835-->C, resulting in an amino acid change, G279R. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2005.05852.xDOI Listing
January 2006
13 Reads

Neurovisceral porphyrias: what a hematologist needs to know.

Hematology Am Soc Hematol Educ Program 2005 :24-30

The Liver-Biliary-Pancreatic Center, University of Connecticut, MC-1111, 263 Farmington Avenue, Farmington, CT 06030, USA.

The acute or inducible hepatic porphyrias comprise four inherited disorders of heme biosynthesis. They usually remain asymptomatic for most of the lifespan of individuals who inherit the specific enzyme deficiencies but may cause life-threatening attacks of neurovisceral symptoms. Failure to consider the diagnosis frequently delays effective treatment, and inappropriate diagnostic tests and/or mistaken interpretation of results may lead to misdiagnosis and inappropriate treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2005.1.24DOI Listing
November 2009
17 Reads

The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany.

J Inherit Metab Dis 2004 ;27(4):529-36

Clinical Biochemistry--Consultation Porphyria, Postfach 12 20, D-35002 Marburg an der Lahn, Germany.

Delta-aminolevulinic acid dehydratase (ALAD) deficiency porphyria, or Doss porphyria, was first reported in Germany in 1979. Only four bona fide cases of Doss porphyria have been reported to date that were confirmed by immunological and molecular analyses of their ALAD mutations. Here we describe the fifth case of Doss porphyria. Read More

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1023/B:BOLI.0000037341.21975.9d
Publisher Site
http://dx.doi.org/10.1023/B:BOLI.0000037341.21975.9dDOI Listing
January 2005
13 Reads

Late-onset porphyrias: what are they?

Cell Mol Biol (Noisy-le-grand) 2002 Feb;48(1):97-101

Laboratory of Biochemical Hematology, The Rockefeller University, New York, NY 10021, USA.

Porphyrias are inherited disorders of heme biosynthesis. ALA dehydratase porphyria (ADP) and congenital erythropoietic porphyria (CEP) are autosomal recessive porphyrias, and are typically expressed at birth or in childhood. However, a few cases of late-onset recessive porphyrias have been reported. Read More

View Article

Download full-text PDF

Source
February 2002
15 Reads

Genetic rescue of Leishmania deficiency in porphyrin biosynthesis creates mutants suitable for analysis of cellular events in uroporphyria and for photodynamic therapy.

J Biol Chem 2002 Apr 8;277(17):14902-9. Epub 2002 Feb 8.

Department of Microbiology, University of Health Sciences, Chicago Medical School, North Chicago, Illinois 60064, USA.

Leishmania was found deficient in at least five and most likely seven of the eight enzymes in the heme biosynthesis pathway, accounting for their growth requirement for heme compounds. The xenotransfection of this trypanosomatid protozoan led to their expression of the mammalian genes encoding delta-aminolevulinate (ALA) dehydratase and porphobilinogen deaminase, the second and the third enzymes of the pathway, respectively. These transfectants still require hemin or protoporphyrin IX for growth but produce porphyrin when ALA was supplied exogenously. Read More

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M200107200
Publisher Site
http://dx.doi.org/10.1074/jbc.M200107200DOI Listing
April 2002
25 Reads

Porphyrin biosynthesis intermediates are not regulating delta-aminolevulinic acid transport in Saccharomyces cerevisiae.

Biochem Biophys Res Commun 2000 Jun;272(3):946-50

Centro de Investigaciones sobre Porfirinas y Porfirias, CIPYP (CONICET, FCEyN, UBA), Ciudad Universitaria, Buenos Aires, Argentina.

In Saccharomyces cerevisiae, as in all eukaryotic organisms, delta-aminolevulinic acid (ALA) is a precursor of porphyrin biosynthesis, a very finely regulated pathway. ALA enters yeast cells through the gamma-aminobutyric acid (GABA) permease Uga4. The incorporation of a metabolite into the cells may be a limiting step for its intracellular metabolization. Read More

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0092874
Publisher Site
http://dx.doi.org/10.1006/bbrc.2000.2874DOI Listing
June 2000
18 Reads

Investigations on the formation of urinary coproporphyrin isomers I-IV in 5-aminolevulinic acid dehydratase deficiency porphyria, acute lead intoxication and after oral 5-aminolevulinic acid loading.

Clin Biochem 1999 Mar;32(2):119-23

Institute of Clinical Chemistry, University Hospital Grosshadern, Munich, Germany.

Objectives: Investigation of the metabolism of the four urinary coproporphyrin isomers I-IV in the extremely rare 5-aminolevulinic acid dehydratase (ALAD) deficiency porphyria (syn.: Doss porphyria), in acute lead intoxication, and after oral 5-aminolevulinic acid (ALA) loading.

Design And Methods: We analyzed the excretion of total urinary coproporphyrins and the composition of the respective isomers I-IV with ion-pair HPLC methods in these conditions. Read More

View Article

Download full-text PDF

Source
March 1999
13 Reads

5-Aminolevulinic acid dehydratase deficiency porphyria: a twenty-year clinical and biochemical follow-up.

Clin Chem 1998 Sep;44(9):1892-6

Division of Clinical Biochemistry, Philipps University Hospital, Marburg, Germany.

5-Aminolevulinic acid dehydratase (ALAD) activity in two patients with compound heterozygous 5-aminolevulinic acid dehydratase deficiency porphyria was studied over the last 20 years. The patients' enzyme activity was <10% from 1977 to 1997. An acute crisis in each patient was successfully treated by infusion of glucose and heme arginate. Read More

View Article

Download full-text PDF

Source
September 1998
12 Reads

ALAD porphyria.

Authors:
S Sassa

Semin Liver Dis 1998 ;18(1):95-101

Laboratory for Biochemical Hematology, Rockefeller University, New York, N.Y. 10021, USA.

ALAD porphyria is an autosomal recessive disorder resulting from a homozygous aminolevulinic acid dehydratase (ALAD) deficiency. Because of an almost complete lack of ALAD activity, patients excrete a large amount of ALA, but not PBG, into urine. The symptoms in this disease are similar to those seen in AIP, but ALAD porphyria can be differentiated from AIP by its autosomal recessive, rather than dominant, inheritance, by the lack of PBG overproduction, and by markedly decreased ALAD activity. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-2007-1007145
Publisher Site
http://dx.doi.org/10.1055/s-2007-1007145DOI Listing
May 1998
7 Reads

Acute porphyrias: pathogenesis of neurological manifestations.

Semin Liver Dis 1998 ;18(1):43-52

University of Basel, Dept. Pharmacology, Switzerland.

Four types of hepatic porphyria (acute intermittent porphyria; hereditary coprophorphyria; variegate porphyria; delta-aminolevulinate dehydratase deficiency porphyria) present clinically with an identical neurological syndrome. Symptoms include severe abdominal pain, vomiting, constipation, hypertension, tachycardia, and bladder dysfunction. These symptoms have been ascribed to autonomic neuropathy. Read More

View Article

Download full-text PDF

Source
http://www.thieme-connect.de/DOI/DOI?10.1055/s-2007-1007139
Publisher Site
http://dx.doi.org/10.1055/s-2007-1007139DOI Listing
May 1998
12 Reads

Increased delta aminolevulinic acid and decreased pineal melatonin production. A common event in acute porphyria studies in the rat.

J Clin Invest 1996 Jan;97(1):104-10

Centre Français des Porphyries, Institut National de la Santé et de la Recherche Médicale, Hôpital Louis Mourier, Colombes, France.

Tryptophan (TRP) is the precursor of melatonin, the primary secretory product of the pineal gland. Hepatic heme deficiency decreases the activity of liver tryptophan pyrrolase, leading to increased plasma TRP and serotonin. As a paradox, patients with attacks of acute intermittent porphyria (AIP), exhibit low nocturnal plasma melatonin levels. Read More

View Article

Download full-text PDF

Source
http://www.jci.org/articles/view/118376
Publisher Site
http://dx.doi.org/10.1172/JCI118376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC507067PMC
January 1996
11 Reads

delta-Aminolevulinic acid dehydratase deficiency porphyria (ADP) with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in a 69-year-old woman.

Kobe J Med Sci 1995 Apr;41(1-2):23-31

Department of Internal Medicine, Suma Red Cross Hospital, Kobe, Japan.

delta-Aminolevulinic acid dehydratase deficiency porphyria (ALAD porphyria, ADP) with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in a 69-year-old woman is reported. The patient was admitted to our hospital complaining of slight cough with low-grade fever, and treated with piperacillin sodium, resulting in complete resolution of the symptoms, following a diagnosis of bronchopneumonia. Thereafter, however, she began to complain of vomiting, abdominal pain, facial numbness and paresis of the extremities with gait disturbance, and became comatose with hyponatremia (serum Na concentration 119 mEq/L) in a few days. Read More

View Article

Download full-text PDF

Source
April 1995
15 Reads

delta-Aminolevulinate dehydratase deficient porphyria: identification of the molecular lesions in a severely affected homozygote.

Am J Hum Genet 1991 Jul;49(1):167-74

Division of Medical and Molecular Genetics, Mount Sinai School of Medicine, New York, NY 10029.

delta-Aminolevulinate dehydratase deficient porphyria, a recently recognized inborn error of heme biosynthesis, results from the markedly deficient activity of the heme biosynthetic enzyme, delta-aminolevulinate dehydratase (ALA-D). The four homozygotes described to date with this disorder have remarkably distinct phenotypes, ranging from a severely affected infant with failure to thrive to an essentially asymptomatic 68-year-old male. To investigate the molecular nature of the lesions causing the severe infantile-onset form, total RNA was isolated from cultured lymphoblasts of the affected homozygote, RNA was reverse-transcribed to cDNA, and the 990-bp ALA-D-coding region was amplified by the PCR. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1683193PMC
July 1991
24 Reads

Hereditary hepatic porphyria due to homozygous delta-aminolevulinic acid dehydratase deficiency: studies in lymphocytes and erythrocytes.

Eur J Clin Invest 1991 Apr;21(2):244-8

Rockefeller University Hospital, New York, NY 10021.

Activities of delta-aminolevulinic acid (ALA) dehydratase and porphobilinogen (PBG) deaminase, and haem content were determined in EB-virus transformed lymphocytes from two patients with homozygous ALA dehydratase deficiency, and their family members to determine the expression of the specific gene defect in this cell type. ALA dehydratase activity, but not PBG deaminase activity or haem content, was markedly decreased in lymphocyte preparations from both patients with homozygous enzyme deficiency, and moderately decreased in subjects heterozygous for enzyme deficiency. Immunochemical quantitation of erythrocyte ALA dehydratase suggested the presence of a cross-reactive material in a patient with a late-onset of acute hepatic porphyria due to the homozygous enzyme deficiency. Read More

View Article

Download full-text PDF

Source
April 1991
10 Reads

Porphyric neuropathy and hereditary delta-aminolevulinic acid dehydratase deficiency in an adult.

J Neurol Sci 1990 Jan;95(1):39-47

Department of Neurology, University Hospital of Antwerp, Belgium.

A man without a history of porphyric attacks developed a subacute motor neuropathy at the age of 63. At the same time the first signs of a myeloproliferative disorder were found. He had a homozygous deficiency of erythrocyte delta-aminolevulinic acid dehydratase (ALA-D) with autosomal recessive inheritance. Read More

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/0022510X90901154/1-s2.0-0022510X909011
Web Search
January 1990
8 Reads

Enzyme replacement therapy in porphyrias--V. In vivo correction of delta-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts.

Drug Des Deliv 1989 Dec;5(2):125-31

Centro de Investigaciones sobre Porfirinas y Porfirias CIPYP-(CONICET & FCEN, University of B. Aires)-Ciudad Universitaria, Argentine.

Resealed erythrocyte ghosts are potential in vivo carriers of exogenous therapeutic enzymes. In the present work, the effect of administering delta-aminolaevulinate dehydratase (ALA-D) encapsulated in autologous red blood cell ghosts (RBCg) to lead intoxicated and normal mice was investigated. Administration of ALA-D loaded RBCg to intoxicated mice produced an immediate and permanent recovery in erythrocytic ALA-D activity; the effect was also noticeable in liver and spleen and absent in kidney, indicating that the entrapped enzyme was significantly stabilized to allow retention of activity in both circulating and phagocytized cells. Read More

View Article

Download full-text PDF

Source
December 1989
15 Reads

In inherited porphyrias, lead intoxication is a toxogenetic disorder.

Int J Biochem 1987 ;19(8):717-20

1. delta-Aminolevulinic acid dehydratase (ALA-D), blood lead and several enzymes and metabolites of the heme biosynthetic pathway were measured in a number of symptomatic porphyric patients, 22 with acute intermittent porphyria, three with hereditary hepatic coproporphyria, 10 with hereditary porphyria cutanea tarda, two with erythropoietic protoporphyria and two with congenital erythropoietic porphyria and in 84 lead intoxicated persons. 2. Read More

View Article

Download full-text PDF

Source
October 1987
12 Reads

delta-Aminolevulinic acid dehydrase (porphobilinogen synthase) in two families with inherited enzyme deficiency.

Clin Genet 1986 Sep;30(3):191-8

The inheritance of a deficient delta-aminolevulinic acid dehydrase (ALA-D; synonym: porphobilinogen synthase; EC 4.2.1. Read More

View Article

Download full-text PDF

Source
September 1986
11 Reads

Hereditary hepatic porphyria with delta aminolevulinate dehydrase deficiency: immunologic characterization of the non-catalytic enzyme.

Hum Genet 1985 ;69(2):174-7

Immunoreactive delta-aminolevulinate dehydrase (ALA-D) was measured in lysates from two porphyric patients with ALA-D deficiency (enzyme activities were below 2% of the normal level). By using two different immunologic methods, we found a cross-reactive immunologic material (CRIM+) which corresponded to 20% and 33% of the control level. Therefore the molecular basis that accounts for the deficiency of ALA-D in these patients is a structurally modified enzyme. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/BF00293292.pdf
Web Search
April 1985
10 Reads

Simple screening test for qualitative detection of increased delta-aminolevulinic acid in urine.

Clin Chem 1984 Aug;30(8):1372-3

A simple qualitative procedure for demonstrating increased delta-aminolevulinic acid (ALA) in urine is needed to identify individuals with an inherited deficiency of the enzyme ALA dehydratase, a newly described porphyria-like syndrome. The present procedure includes two steps, the last of which is carried out only on samples that are positive in the first step. Urine is tested for pyrroles, preformed or formed by heating with acetylacetone, by looking for a pink color after p-dimethylaminobenzaldehyde is added. Read More

View Article

Download full-text PDF

Source
August 1984
8 Reads

Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.

Authors:
S Sassa A Kappas

J Clin Invest 1983 Mar;71(3):625-34

Succinylacetone (4,6-dioxoheptanoic acid) is an abnormal metabolite produced in patients with hereditary tyrosinemia as a consequence of an inherited deficiency of fumarylacetoacetate hydrolase. It is known that patients with this hereditary disease excrete excessive amounts of delta-aminolevulinic acid (ALA) in urine and that certain patients have an accompanying clinical syndrome resembling that of acute intermittent porphyria (AIP). In order to elucidate the relation of succinylacetone to the heme biosynthetic pathway, we have examined the effects of this metabolite on the cellular heme content of cultured avian hepatocytes and on the activity of purified ALA dehydratase from normal human erythrocytes and from mouse and bovine liver. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC436912PMC
March 1983
12 Reads

Abnormal haem biosynthesis in chronic alcoholics.

Eur J Clin Invest 1981 Dec;11(6):461-8

The activities of six of the enzymes of haem biosynthesis have been examined in eleven chronic alcoholics admitted to hospital for alcohol withdrawal. The mitochondrial enzymes delta-aminolaevulinic acid (ALA) synthase, coproporphyrinogen oxidase and ferrochelatase were monitored in peripheral leucocytes and the cytosolic enzymes ALA dehydratase, uroporphyrinogen-1-synthase and uroporphyrinogen decarboxylase in peripheral erythrocytes. Compared with control subjects the activity of the initial and rate controlling enzyme of the pathway, ALA synthase, was increased (P less than 0. Read More

View Article

Download full-text PDF

Source
December 1981
7 Reads

Inherited deficiency of delta-aminolevulinic acid dehydratase.

Am J Hum Genet 1979 Nov;31(6):662-8

Delta-aminolevulinic acid dehydratase (ALA-D) is the second enzyme in the porphyrin-heme pathway and converts delta-aminolevulinc acid (ALA) to porphobilinogen (PBG). A family is reported with an inherited deficiency of red cell ALA-D activity occurring over three generations in an autosomal dominant pattern. Intial experiments support the hypothesis that the mutation in this family may affect a regulatory gene, but enzyme purification and further study are required. Read More

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1686033PMC
November 1979
8 Reads

Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.

J Clin Invest 1978 Feb;61(2):499-508

A 50% reduction in the activity of uroporphyrinogen-I (URO) synthase in liver, erythrocytes, and cultured skin fibroblasts characterizes all patients with clinically active acute intermittent porphyria (AIP). The same enzyme defect has also been demonstrated in the erythrocytes and skin fibroblasts of completely latent gene carriers of this disorder and presumably exists in the liver as well. In this study, we examined whether or not the formation of URO-synthase is impaired in AIP cells using lymphocytes treated with mitogens or infected with Epstein-Barr virus. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI108961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC372561PMC
February 1978
20 Reads

The activities of uroporphyrinogen synthetase and cosynthetase in congenital erythropoietic porphyria (CEP).

Am J Hematol 1976 ;1(1):3-21

Normal or increased amounts of series III porphyrins with greater amounts of series I were observed on incubation of PBG in hemolysates of congenital erythropoietic porphyria vs. normal erythrocytes, human or bovine. Correlation with reticulocyte percentage was poor, in the aggregate a general trend toward increased values of both isomers I and III was noted with increasing reticulocytes. Read More

View Article

Download full-text PDF

Source
January 1977
11 Reads
  • Page 1 of 1